REQUEST A DEMO
Total
USD $0.00
Search more companies

Cellpeutics Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: Other Miscellaneous Manufacturing | Merchant Wholesalers, Durable Goods | Scientific Research and Development Services | Ambulatory Health Care Services
Full name: Cellpeutics Sp. z o.o. Profile Updated: May 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Cellpeutics Sp. z o.o. is based in Poland, with the head office in Wroclaw. The enterprise currently operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) sector. It was incorporated on December 11, 2015. There are currently 1 (2016) people employed by Cellpeutics Sp. z o.o.. A negative growth of 16.48% was recorded in its total assets.

Headquarters
Ul. Dunska 9
Wroclaw; Dolnoslaskie; Postal Code: 54-427

Contact Details: Purchase the Cellpeutics Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Cellpeutics Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Cellpeutics Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Cellpeutics Sp. z o.o. report to view the information.
Incorporation Date:
December 11, 2015
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
49%
Company Performance
Financial values in the chart are available after Cellpeutics Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
-99.01%
Operating profit (EBIT)
19.98%
Net Profit (Loss) for the Period
19.98%
Total assets
-16.48%
Total equity
-49.89%
Return on Equity (ROE)
-37.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?